UC Davis Scientist Awarded $1.36M to Develop Angelman Gene Therapy
A professor at the University of California (UC) Davis Health has been awarded a $1.36 million Discovery Stage Research Projects (DISC2) grant to develop a gene therapy for Angelman syndrome, according to a university press release. David Segal, PhD, a professor in the departments of biochemistry and molecular…